SCHEMBL6777423

SCHEMBL6777423

COC(=O)c1cc(N)cc2c1OCCCN2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.43
ALDH1A1 P00352 6/20 0.43
GAA P10253 6/20 0.36
HSD17B10 Q99714 4/20 0.33
MAPT P10636 3/20 0.33
HPGD P15428 3/20 0.33
GLA P06280 2/20 0.33
TSHR P16473 2/20 0.33
FUCA1 P04066 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
ATM Q13315 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CFTR P13569 2/20 0.33
ABL1 P00519 1/20 0.33
OPRK1 P41145 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NQO2 P16083 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7409675 0.84 ALDH1A1 (0.37) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL7410744 0.84 SERPINH1 (0.39) KDM4EALDH1A1HSD17B10MAPTHPGD
SCHEMBL7416511 0.83 YAP1 (0.41) KDM4EALDH1A1GAAHSD17B10
SCHEMBL7410107 0.81 ALDH1A1 (0.35) KDM4EALDH1A1HSD17B10MAPTHPGD
SCHEMBL6368737 0.80 ALDH1A1 (0.38) KDM4EALDH1A1MAPTOPRK1SMN1; SMN2
SCHEMBL7412325 0.79 ALDH1A1 (0.33) KDM4EALDH1A1FUCA1NPC1RAB9A
SCHEMBL6373245 0.78 KDM4E (0.54) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL6375487 0.77 HPGD (0.43) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL6374998 0.77 HRH4 (0.38) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL7409129 0.76 HTR4 (0.40) KDM4EALDH1A1GAAABL1NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6821977-B2 SUBSTITUTED 1H-(INDOLE-2- CARBOXAMIDES AND 6H-THIENO(2,3-B)PYRROLE-5-CARBOXAMIDES USEFUL FOR INHIBITING GLYCOGEN PHOSPHORYLASE IN A MAMMAL PFIZER, INC. 2004-11-23 US disclosed
US-20030199553-A1 Antidiabetic agents GAMMILL RONALD B (US) 2003-10-23 US disclosed
WO-2003072570-A1 ANTIDIABETIC AGENTS PFIZER PRODUCTS INC. (US) 2003-09-04 WO disclosed
EP-1340500-A1 Antidiabetic agents Pfizer Products Inc. (US) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199553-A1 Antidiabetic agents GPR119, IRS1, INSR KDM4E 4333/4885ALDH1A1 1021/4885GAA 1059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.